HealthSouth Corp. Hits New 52-Week High at $33.97 (HLS)
HealthSouth Corp. (NYSE:HLS)’s share price reached a new 52-week high during trading hours on Monday, Stock Ratings Network.com reports. The company traded as high as $33.97 and last traded at $33.65, with a volume of 178,131 shares traded. The stock had previously closed at $33.42.
A number of analysts have recently weighed in on HLS shares. Analysts at Mizuho raised their price target on shares of HealthSouth Corp. (NYSE:HLS) from $36.00 to $39.00 in a research note to investors on Friday, August 16th. They now have a “buy” rating on the stock. Separately, analysts at Stifel Nicolaus raised their price target on shares of HealthSouth Corp. (NYSE:HLS) from $30.00 to $36.00 in a research note to investors on Friday, July 26th. They now have a “buy” rating on the stock.
Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $32.66.
HealthSouth Corp. has a one year low of $19.85 and a one year high of $33.97. The stock’s 50-day moving average is $32.44 and its 200-day moving average is $29.25. The company has a market cap of $2.947 billion and a P/E ratio of 11.07.
HealthSouth Corp. (NYSE:HLS) last posted its quarterly earnings results on Thursday, July 25th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.09. The company had revenue of $564.50 million for the quarter, compared to the consensus estimate of $553.63 million. During the same quarter last year, the company posted $0.39 earnings per share. HealthSouth Corp.’s revenue was up 5.8% compared to the same quarter last year. Analysts expect that HealthSouth Corp. will post $1.81 EPS for the current fiscal year.
HealthSouth Corporation (NYSE:HLS) is an owner and operator of inpatient rehabilitation hospitals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.